Vaping and smoking study for people with schizophrenia
Part of Mental health clinical trials.
This study looks at habits of vaping and smoking in people with schizophrenia. It may help researchers understand how to better support people who want to reduce or quit nicotine use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been vaping or smoking nicotine most days for at least 6 months
- You have a stable dose of antipsychotic medication (no changes in the past 6 months)
- You are not planning to quit vaping or smoking in the next month
- You are not currently using any smoking-cessation medication (like patches or gum)
- You do not have severe substance problems (other than nicotine) or suicidal thoughts with a plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at nicotine withdrawal symptoms in people who vape and/or smoke regularly. It may help improve how quitting support is tailored, based on how participants respond during the withdrawal period.
This study looks at what happens when people who vape nicotine daily try to cut back. Researchers want to understand withdrawal symptoms and find better ways to help people reduce or quit vaping.
This study offers a way to reduce harm from smoking for people with mental health conditions who are not ready to quit. It tests if switching to a less harmful product can help improve health without requiring you to stop smoking completely.
This study tests whether nicotine replacement therapy (like patches or gum) helps people who regularly vape nicotine stop vaping. If you're interested in quitting in the next few months, this study may be able to support you.
This study tests whether using e-cigarettes with a tobacco flavor or a non-tobacco flavor helps people who smoke switch away from regular cigarettes. Participants will use either e-cigarettes or nicotine replacement therapy for a period of time, and researchers will track their smoking behavior.
This trial tests whether varenicline helps people with schizophrenia or schizoaffective disorder stop smoking. It also looks at related nervous-system side effects that can happen with some anti-psychotic medicines.
Hear when a new Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.